ELISA binding of GenCRISPRᵀᴹ SaCas9 Antibody (26H10) (GenScript, A01952-40) with recombinant Staphylococcus aureus CRISPR/Cas9 protein.
Coating antigen: SaCas9, 1 µg/ml.
SaCas9 antibody dilution start from 1000 ng/ml,EC₅₀= 2.109 ng/ml.
Standard curve of SaCas9 Sandwich ELISA. The SaCas9 Sandwich ELISA assay is developed by using GenCRISPRᵀᴹ SaCas9 Antibody (11C12) (GenScript, A01951-40) and GenCRISPRᵀᴹ SaCas9 Antibody (26H10) (GenScript, A01952-40) as capture and detection antibody, respectively. These two antibodies recognize different epitopes.
In this ELISA assay, GenCRISPRᵀᴹ SaCas9 Antibody (26H10) (GenScript, A01952-40) was labeled with Biotin. GenScript can provide customized conjugation service for this product per customer's request.
The sensitivity is <1 ng/ml and the detection range is 0-30 ng/ml.
Western Blot analysis of Hela transfected with various plasmids with GenCRISPRᵀᴹ SaCas9 Antibody (26H10) (GenScript, A01952-40). The different Hela transfected with various plasmids indicate the minimum cross reaction of the antibody.
Predicted band size: 124 kDa
Loading:
Lane 1: 50μg Hela cell lysate transfected with StCas9(BB)-2A-GFP (G3ECR1, Streptococcus thermophiles)
Lane 2: 50μg Hela cell lysate transfected with pSpCas9(BB)-2A-GFP (PX458, Q99ZW2, Streptococcus pyogenes serotype M1)
Lane 3: 50μg Hela cell lysate transfected with SaCas9(BB)-2A-GFP (J7RUA5, Staphylococcus aureus)
Lane 4: 50μg Hela cell lysate transfected with AsCpf1(BB)-2A-GFP (U2UMQ6, Acidaminococcus sp. (strain BV3L6))
Lane 5: 50μg Hela cell lysate transfected with FnCpf1(BB)-2A-GFP (A0Q7Q2, Francisella tularensis subsp. novicida (strain U112))
Lane 6: 50μg Hela cell lysate transfected with LbCpf1(BB)-2A-GFP (A0A182DWE3, Lachnospiraceae bacterium ND2006)
Lane 7: 50μg Hela cell lysate (Non-transfected)
Primary Antibody:
Lane 1~7: GenCRISPRᵀᴹ SaCas9 Antibody (26H10) (GenScript, A01952-40) 1 μg/ml
Secondary antibody:
Goat anti-Mouse IgG (H&L) [IRDye⁸⁰⁰] , 0.125 μg/ml
GenCRISPR™ SaCas9 Antibody (26H10), mAb, Mouse
A01952 | |
|
|
¥17,089.00 | |
|
|
|
|
Ask us a question |